Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Denosumab injection (Prolia®)	TA204 - Denosumab for the prevention of osteoporotic fractures in postmenopausal women	ESCA
Dermablend®
Dermacolor®
Dermatonics Once Heel Balm®		Specialist recommendation for epidermolysis bullosa and diabetes patients only
Dexamethasone 0.1% eye drops		Eye drops. Single dose unit drops - for post corneal transplant or OSD - use the agent with the lowest acquisition cost.
Dexamethasone 0.1% single dose unit drops		For post corneal transplants or OSD - use the agents with the lowest acquisition cost
Dexamfetamine tablets	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	ESCAs and additional advice in relation to age of patient and CCG
Diclofenac sodium - Voltarol® Ophtha multidose
Diethylstilbestrol tablets		Extremely high relative cost
Diflucortolone valerate 0.3% oily cream		Very potent

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.